No Data
No Data
Express News | 'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment
Compass Pathways to Participate in Stifel Virtual CNS Forum
Compass Pathways Price Target Maintained With a $45.00/Share by HC Wainwright & Co.
COMPASS Pathways: Positioned for Transformative Growth in Neuropsychiatry With COMP360 Advancements
BTIG Maintains COMPASS Pathways(CMPS.US) With Buy Rating, Maintains Target Price $12
TD Cowen Maintains COMPASS Pathways(CMPS.US) With Buy Rating, Maintains Target Price $23